Literature DB >> 12881132

Lack of de-epoxidation of type B trichothecenes in incubates with human faeces.

G Sundstøl Eriksen1, H Pettersson.   

Abstract

The ability of human gastrointestinal organisms to transform the trichothecenes 3-acetyldeoxynivalenol and nivalenol was investigated. Samples of human faeces were incubated under anaerobic conditions for 48 h with the toxins. They were then extracted and analysed for trichothecenes and metabolites. 3-acetyldeoxynivalenol was metabolized to deoxynivalenol during the incubation period. In contrast to what has been reported for other species such as rats, mice and pigs, no de-epoxidated metabolites were detected in the faecal incubates. The toxicological significance of the difference in the intestinal ability to transform trichothecenes between species is unknown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881132     DOI: 10.1080/0265203031000102573

Source DB:  PubMed          Journal:  Food Addit Contam        ISSN: 0265-203X


  13 in total

Review 1.  Xenobiotics: Interaction with the Intestinal Microflora.

Authors:  Kun Lu; Ridwan Mahbub; James G Fox
Journal:  ILAR J       Date:  2015

2.  Assessment of deoxynivalenol metabolite profiles in UK adults.

Authors:  Paul C Turner; Richard P Hopton; Kay L M White; Julie Fisher; Janet E Cade; Christopher P Wild
Journal:  Food Chem Toxicol       Date:  2010-10-08       Impact factor: 6.023

3.  A biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study.

Authors:  P C Turner; B T Ji; X O Shu; W Zheng; W H Chow; Y T Gao; L J Hardie
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-07-20

4.  The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol.

Authors:  Silvia W Gratz; Gary Duncan; Anthony J Richardson
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

5.  Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.

Authors:  James J Pestka; Chidozie J Amuzie
Journal:  Food Chem Toxicol       Date:  2008-07-09       Impact factor: 6.023

6.  Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches.

Authors:  El Hassan Ajandouz; Stéphane Berdah; Vincent Moutardier; Thierry Bege; David Jérémie Birnbaum; Josette Perrier; Eric Di Pasquale; Marc Maresca
Journal:  Toxins (Basel)       Date:  2016-07-28       Impact factor: 4.546

7.  Sex Is a Determinant for Deoxynivalenol Metabolism and Elimination in the Mouse.

Authors:  James J Pestka; Erica S Clark; Heidi E Schwartz-Zimmermann; Franz Berthiller
Journal:  Toxins (Basel)       Date:  2017-08-04       Impact factor: 4.546

8.  Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography-High-Resolution Mass Spectrometry.

Authors:  Irina Slobodchikova; Reajean Sivakumar; Md Samiur Rahman; Dajana Vuckovic
Journal:  Toxins (Basel)       Date:  2019-07-24       Impact factor: 4.546

9.  Nivalenol and deoxynivalenol affect rat intestinal epithelial cells: a concentration related study.

Authors:  Giuseppe Bianco; Bianca Fontanella; Lorella Severino; Andrea Quaroni; Giuseppina Autore; Stefania Marzocco
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Urinary deoxynivalenol is correlated with cereal intake in individuals from the United kingdom.

Authors:  Paul C Turner; Joseph A Rothwell; Kay L M White; Yunyun Gong; Janet E Cade; Christopher P Wild
Journal:  Environ Health Perspect       Date:  2008-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.